Study of SFRP1 and SFRP2 Genes Methylation Status in Patients with De Novo Acute Myeloblastic Leukemia

Background: Acute myeloid leukemia (AML) is a heterogeneous group of hematologic malignancies with great variability in the pathogenesis and clinical course. DNA methylation of CpG islands within the promoters of specific genes may play roles in tumor initiation and progression. Secreted frizzled-re...

Full description

Bibliographic Details
Main Authors: Ali Ghasemi, Shahrbanoo Rostami, Nasrin Alizad-Ghandforosh, Abbas Ghotaslou, Sadegh Abbasian, Fatemeh Nadali
Format: Article
Language:fas
Published: Vesnu Publications 2014-07-01
Series:مجله دانشکده پزشکی اصفهان
Subjects:
Online Access:http://jims.mui.ac.ir/index.php/jims/article/view/3809
id doaj-7963c30bbdfa4d1ab8e6f4dad9ccfcee
record_format Article
spelling doaj-7963c30bbdfa4d1ab8e6f4dad9ccfcee2020-11-25T00:11:02ZfasVesnu Publications مجله دانشکده پزشکی اصفهان1027-75951735-854X2014-07-01322867027111615Study of SFRP1 and SFRP2 Genes Methylation Status in Patients with De Novo Acute Myeloblastic LeukemiaAli Ghasemi0Shahrbanoo Rostami1Nasrin Alizad-Ghandforosh2Abbas Ghotaslou3Sadegh Abbasian4Fatemeh Nadali5MSc Student, Department of Hematology, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, IranHematology-Oncology and Stem cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, IranMSc Student, Department of Hematology, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, IranMSc Student, Department of Hematology, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, IranMSc Student, Department of Hematology, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, IranAssociate Professor, Department of Hematology, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, IranBackground: Acute myeloid leukemia (AML) is a heterogeneous group of hematologic malignancies with great variability in the pathogenesis and clinical course. DNA methylation of CpG islands within the promoters of specific genes may play roles in tumor initiation and progression. Secreted frizzled-related proteins (SFRPs) are negative regulator of the Wnt signaling pathway. In the present study, we compared the methylation status of SFRP1 and SFRP2 genes promoter in patients with AML and healthy individuals. Methods: In peripheral blood from 43 patients afflicted with de novo AML and 25 healthy controls, isolated DNA was treated with sodium bisulfite and analyzed by methylation-specific polymerase chain reaction (MSP) with primers specific for methylated and unmethylated promoter sequences of the SFRP1 and SFRP2 genes. We used Mann-Whitney u-tests to investigate the correlation between SFRP1 and SFRP2 genes hypermethylation and clinical parameters. Findings: The frequency of aberrant hypermethylation of SFRP1 and SFRP2 genes promoter in patients with AML was determined 30.2% (13/43) and 20.9% (9/43), respectively. In addition, for all subjects in control group, methylation of SFRP1 and SFRP2 genes promoter were negative. Patients with M0 subtype of FAB-AML had the highest incidence of hypermethylation of SFRP1 (P = 0.028) and SFRP2 (P = 0.004) genes promoter. Conclusion: The present study showed that, like many solid tumors, SFRPs genes methylation also occurs in AML. Therefore, the methylation of these genes may play a role in leukemogenesis initiation.http://jims.mui.ac.ir/index.php/jims/article/view/3809Acute myeloblastic leukemiaSFRP geneDNA Methylation
collection DOAJ
language fas
format Article
sources DOAJ
author Ali Ghasemi
Shahrbanoo Rostami
Nasrin Alizad-Ghandforosh
Abbas Ghotaslou
Sadegh Abbasian
Fatemeh Nadali
spellingShingle Ali Ghasemi
Shahrbanoo Rostami
Nasrin Alizad-Ghandforosh
Abbas Ghotaslou
Sadegh Abbasian
Fatemeh Nadali
Study of SFRP1 and SFRP2 Genes Methylation Status in Patients with De Novo Acute Myeloblastic Leukemia
مجله دانشکده پزشکی اصفهان
Acute myeloblastic leukemia
SFRP gene
DNA Methylation
author_facet Ali Ghasemi
Shahrbanoo Rostami
Nasrin Alizad-Ghandforosh
Abbas Ghotaslou
Sadegh Abbasian
Fatemeh Nadali
author_sort Ali Ghasemi
title Study of SFRP1 and SFRP2 Genes Methylation Status in Patients with De Novo Acute Myeloblastic Leukemia
title_short Study of SFRP1 and SFRP2 Genes Methylation Status in Patients with De Novo Acute Myeloblastic Leukemia
title_full Study of SFRP1 and SFRP2 Genes Methylation Status in Patients with De Novo Acute Myeloblastic Leukemia
title_fullStr Study of SFRP1 and SFRP2 Genes Methylation Status in Patients with De Novo Acute Myeloblastic Leukemia
title_full_unstemmed Study of SFRP1 and SFRP2 Genes Methylation Status in Patients with De Novo Acute Myeloblastic Leukemia
title_sort study of sfrp1 and sfrp2 genes methylation status in patients with de novo acute myeloblastic leukemia
publisher Vesnu Publications
series مجله دانشکده پزشکی اصفهان
issn 1027-7595
1735-854X
publishDate 2014-07-01
description Background: Acute myeloid leukemia (AML) is a heterogeneous group of hematologic malignancies with great variability in the pathogenesis and clinical course. DNA methylation of CpG islands within the promoters of specific genes may play roles in tumor initiation and progression. Secreted frizzled-related proteins (SFRPs) are negative regulator of the Wnt signaling pathway. In the present study, we compared the methylation status of SFRP1 and SFRP2 genes promoter in patients with AML and healthy individuals. Methods: In peripheral blood from 43 patients afflicted with de novo AML and 25 healthy controls, isolated DNA was treated with sodium bisulfite and analyzed by methylation-specific polymerase chain reaction (MSP) with primers specific for methylated and unmethylated promoter sequences of the SFRP1 and SFRP2 genes. We used Mann-Whitney u-tests to investigate the correlation between SFRP1 and SFRP2 genes hypermethylation and clinical parameters. Findings: The frequency of aberrant hypermethylation of SFRP1 and SFRP2 genes promoter in patients with AML was determined 30.2% (13/43) and 20.9% (9/43), respectively. In addition, for all subjects in control group, methylation of SFRP1 and SFRP2 genes promoter were negative. Patients with M0 subtype of FAB-AML had the highest incidence of hypermethylation of SFRP1 (P = 0.028) and SFRP2 (P = 0.004) genes promoter. Conclusion: The present study showed that, like many solid tumors, SFRPs genes methylation also occurs in AML. Therefore, the methylation of these genes may play a role in leukemogenesis initiation.
topic Acute myeloblastic leukemia
SFRP gene
DNA Methylation
url http://jims.mui.ac.ir/index.php/jims/article/view/3809
work_keys_str_mv AT alighasemi studyofsfrp1andsfrp2genesmethylationstatusinpatientswithdenovoacutemyeloblasticleukemia
AT shahrbanoorostami studyofsfrp1andsfrp2genesmethylationstatusinpatientswithdenovoacutemyeloblasticleukemia
AT nasrinalizadghandforosh studyofsfrp1andsfrp2genesmethylationstatusinpatientswithdenovoacutemyeloblasticleukemia
AT abbasghotaslou studyofsfrp1andsfrp2genesmethylationstatusinpatientswithdenovoacutemyeloblasticleukemia
AT sadeghabbasian studyofsfrp1andsfrp2genesmethylationstatusinpatientswithdenovoacutemyeloblasticleukemia
AT fatemehnadali studyofsfrp1andsfrp2genesmethylationstatusinpatientswithdenovoacutemyeloblasticleukemia
_version_ 1725405485527465984